670 related articles for article (PubMed ID: 15911931)
1. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
2. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
Shumay DM; Maskarinec G; Kakai H; Gotay CC;
J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
[TBL] [Abstract][Full Text] [Related]
3. Men with prostate cancer: making decisions about complementary/alternative medicine.
Boon H; Brown JB; Gavin A; Westlake K
Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
[TBL] [Abstract][Full Text] [Related]
4. Religious and spiritual resources, CAM, and conventional treatment in the lives of cancer patients.
Tatsumura Y; Maskarinec G; Shumay DM; Kakai H
Altern Ther Health Med; 2003; 9(3):64-71. PubMed ID: 12776477
[TBL] [Abstract][Full Text] [Related]
5. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
[TBL] [Abstract][Full Text] [Related]
6. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
7. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
[TBL] [Abstract][Full Text] [Related]
8. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
Chrystal K; Allan S; Forgeson G; Isaacs R
N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer.
Henderson JW; Donatelle RJ
Altern Ther Health Med; 2004; 10(1):52-7. PubMed ID: 14727500
[TBL] [Abstract][Full Text] [Related]
10. Taiwanese adult cancer patients' reports of using complementary therapies.
Lu JH; Tsay SL; Sung SC
Cancer Nurs; 2010; 33(4):320-6. PubMed ID: 20467307
[TBL] [Abstract][Full Text] [Related]
11. Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine.
White M; Verhoef M
Integr Cancer Ther; 2006 Jun; 5(2):117-22. PubMed ID: 16685076
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
Can G; Erol O; Aydiner A; Topuz E
Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
[TBL] [Abstract][Full Text] [Related]
13. Patterns of the use of complementary and alternative medicine in women with metastatic cancer.
Yildirim Y
Cancer Nurs; 2010; 33(3):194-200. PubMed ID: 20357652
[TBL] [Abstract][Full Text] [Related]
14. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
[TBL] [Abstract][Full Text] [Related]
15. The use of complementary therapy by men with prostate cancer in the UK.
Wilkinson S; Farrelly S; Low J; Chakraborty A; Williams R; Wilkinson S
Eur J Cancer Care (Engl); 2008 Sep; 17(5):492-9. PubMed ID: 18637112
[TBL] [Abstract][Full Text] [Related]
16. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
17. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer.
Wyatt G; Sikorskii A; Wills CE; Su H
Nurs Res; 2010; 59(1):58-66. PubMed ID: 20010046
[TBL] [Abstract][Full Text] [Related]
18. Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care?
Evans MA; Shaw AR; Sharp DJ; Thompson EA; Falk S; Turton P; Thompson T
Eur J Cancer Care (Engl); 2007 Nov; 16(6):517-25. PubMed ID: 17944766
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine use in patients with haematological malignancies in Europe.
Molassiotis A; Margulies A; Fernandez-Ortega P; Pud D; Panteli V; Bruyns I; Scott JA; Gudmundsdottir G; Browall M; Madsen E; Ozden G; Magri M; Selvekerova S; Platin N; Kearney N; Patiraki E
Complement Ther Clin Pract; 2005 May; 11(2):105-10. PubMed ID: 15955292
[TBL] [Abstract][Full Text] [Related]
20. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.
Tasaki K; Maskarinec G; Shumay DM; Tatsumura Y; Kakai H
Psychooncology; 2002; 11(3):212-20. PubMed ID: 12112481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
